Home
Documentation

Getting Started Guide

API Reference

Sample Code

Plugin Developer Handbook

Developer Community

Forums

Slack Channel

Facebook Group
Solutions

CERCARE MEDICAL NEUROSUITE

Oncology & Neurology
Stroke

Unique Perfusion Imaging Maps

Explore our unique imaging maps for unparalleled insights and enhanced diagnostic precision.

Get Better Insights now
About us

CERCARE MEDICAL

Cercare Medical
Management Team
Board Members
Investors
Career
History
Vision // Mission // History // People

We are bridging the gap between science and clinical practice.
With our amazing users, we use research to prove new ways for more accurate, more efficient and reliable care to help practitioners act with speed, insight and confidence – no matter the circumstances.
Resources

RESOURCES

Videos
Publications
Support

We are bridging the gap between science and clinical practice.
With our amazing users, we use research to prove new ways for more accurate, more efficient and reliable care to help practitioners act with speed, insight and confidence – no matter the circumstances.
Our approach
News
Contact

ON-DEMAND WEBINAR
Rethinking Perfusion Imaging for Oncology Assessment in Brain

Using perfusion imaging for assessing brain tumors can be complicated as the imaging may suffer from artifacts and require manual steps while providing only limited information on tissue status in brain tumors.

In this webinar Professor Kim Beuschau Mouridsen gives an introduction to a new approach to perfusion imaging that allows to get unique insights into brain tissue oxygenation for reliable tumor grading and prognosis while using your existing imaging protocols.

Speaker

Kim Beuschau Mouridsen, Founder and CEO at Cercare Medical, Professor at Aarhus University

Kim Mouridsen, PhD, MSc is a Professor at Aarhus University. He is the head of Neuroimaging Methods at the Center for Functionally Integrative Neuroscience (CFIN) and MINDLab. Professor Mouridsen has published over 40 papers in peer-reviewed journals including Nature Medicine and holds 6 patent applications.